Ravenel Boykin Curry IV
Eagle Capital Management
Eagle Capital Management Portfolio 13F
Eagle Capital Management Holdings Activity
- Portfolio value:
- $18.68B≈
- # of changes:
- 54
- New positions:
- 54
- Reported for:
- 30 Jun 2013 (Q2)
- Latest filing date:
- 15 Aug 2013
Eagle Capital Management has disclosed a total of 54 changes to the portfolio in the (2013 Q2) SEC report(s): bought 54 totally new position(s).
What stocks did Eagle Capital Management buy in 2013 Q2?
During 2013 Q2 Eagle Capital Management has bought 54 securities out of which top 5 purchases (by % change to portfolio) were (BRK-B) Berkshire Hathaway Inc (new buy), (ORCL) Oracle Corp (new buy), (MSFT) Microsoft Corp (new buy), (AON) Aon PLC (new buy) and (LBTYK) Liberty Global PLC, CL-C (new buy).
54 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Telephone and Data Systems Inc
|
new or own*
|
$24.61
|
+44.80%($35.63)
|
0.00%
|
2013 Q2 or earlier
|
≈ 0.25+ years
|
||||
|
|
Thermo Fisher Scientific Inc
|
new or own*
|
$84.63
|
+578.12%($573.90)
|
2.60%
|
2013 Q2 or earlier
|
≈ 0.25+ years
|
||||
|
|
Titan Machinery Inc
|
new or own*
|
$19.62
|
-1.94%($19.24)
|
0.00%
|
2013 Q2 or earlier
|
≈ 0.25+ years
|
||||
|
|
The Travelers Companies Inc
|
new or own*
|
$79.86
|
+381.45%($384.46)
|
0.00%
|
2013 Q2 or earlier
|
≈ 0.25+ years
|
||||
|
|
UnitedHealth Group Incorporated
|
new or own*
|
$65.48
|
+517.94%($404.63)
|
3.85%
|
2013 Q2 or earlier
|
≈ 0.25+ years
|
||||
|
|
Walmart Inc
|
new or own*
|
$24.83
|
+348.85%($111.45)
|
4.10%
|
2013 Q2 or earlier
|
≈ 0.25+ years
|
||||
|
|
Wells Fargo & Company
|
new or own*
|
$41.23
|
+112.94%($87.80)
|
0.00%
|
2013 Q2 or earlier
|
≈ 0.25+ years
|
||||
|
|
Zoetis Inc
|
new or own*
|
$30.89
|
+151.05%($77.56)
|
0.01%
|
2013 Q2 or earlier
|
≈ 0.25+ years
|
||||
|
|
Nestle SA ADR
|
new or own*
|
$65.78
|
+51.54%($99.68)
|
2.39%
|
2013 Q2 or earlier
|
≈ 0.25+ years
|
||||
|
|
Sanofi ADR
|
new or own*
|
$51.57
|
-16.91%($42.85)
|
0.00%
|
2013 Q2 or earlier
|
≈ 0.25+ years
|
||||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.